Bottom line
Is CSIFX a good fund? The bottom line
CSIFX is the Class A share class of Calvert Balanced Fund, a managed allocation / balanced mutual fund from Morgan Stanley.
Its expense ratio is 0.9% — about $90 a year on every $10,000 invested, cheaper than 51% of allocation / balanced funds we track.
It returned +5.5% over one year, +7.2% a year over five years, +9.0% a year over ten (as of Dec 31, 2025, per its prospectus).
With $1.5 billion in net assets and 630 holdings, its largest position is Morgan Stanley & Co. LLC (5.9%) and the top 10 make up 35.6% of the portfolio.
This share class carries a front-end sales charge of up to 5.25%; a no-load class or ETF alternative can avoid it.
The closest lower-cost alternative we found is VTMFX (0.05%, 52% top-holdings overlap).
What stands out
- 5-year return beat 71% of category peers
- Broadly diversified (630 holdings)
What to watch
- Front-end sales load up to 5.25%
- 12b-1 marketing fee of 0.24% a year
- High turnover (164% a year) can mean more taxable distributions
Updated Nov 19, 2026
What CSIFX invests in
The Funds investment objective is to seek to achieve a competitive total return through an actively managed portfolio of stocks, bonds, and money market instruments which offer income and capital growth opportunity.
The Fund seeks to achieve its investment objective by allocating assets between common stocks and fixed-income securities. Under normal market conditions, the Fund invests between 50% and 75% of its net assets in equity securities and between 25% and 50% of its net assets in fixed-income securities. Stock investments are primarily common stock of large-cap companies. Fixed-income investments are primarily a wide variety of investment grade debt securities, such as corporate debt securities, mortgage-backed securities (MBS) (including commercial mortgage-backed securities and collateralized mortgage obligations (CMOs)), and other asset-backed securities (ABS). An investment grade debt security is rated BBB- or higher by S&P Global Ratings (S&P) or an equivalent rating by another nationally recognized statistical rating organization (NRSRO), including Moodys Investors Service, Inc.…
From the fund's prospectus (filed Jan 27, 2026).
CSIFX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| CSIFX | +5.5% | +7.2% | +9.0% |
| Allocation / Balanced median | +11.0% | +5.7% | +6.7% |
Source: Fund prospectus, as of Dec 31, 2025
What CSIFX costs
On a $10,000 investment, CSIFX's 0.9% expense ratio costs about $90 a year. The prospectus estimates $1,575 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.
CSIFX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Morgan Stanley & Co. LLC | 5.94% |
| 2 | Alphabet Inc | 5.24% |
| 3 | NVIDIA Corp | 5.18% |
| 4 | Apple Inc | 3.92% |
| 5 | Amazon.com Inc | 3.07% |
| 6 | Microsoft Corp | 2.99% |
| 7 | Umbs, Tba | 2.89% |
| 8 | Broadcom Inc | 2.53% |
| 9 | JPMorgan Chase & Co | 2.01% |
| 10 | Eli Lilly & Co | 1.81% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 35.6% of the fund. See all top 25 holdings and asset mix →